Joe Biden Begins Cancer Radiation Therapy
Analysis based on 51 articles · First reported Oct 11, 2025 · Last updated Oct 11, 2025
The news of Joe Biden's aggressive cancer treatment could introduce uncertainty into political discourse, potentially affecting sectors like healthcare and pharmaceuticals due to increased public awareness and policy discussions around cancer research. However, as Joe Biden is no longer in office, the direct market impact is minimal.
Former US President Joe Biden has begun a new phase of treatment for aggressive prostate cancer, which was diagnosed in May and has spread to his bones. He is now undergoing a five-week course of radiation therapy in addition to hormone treatment. This follows a previous Mohs surgery in September to remove skin cancer lesions. Joe Biden, who withdrew from the 2024 presidential race due to health concerns, had a Gleason score of 9, indicating a highly aggressive form of the disease. His health has been a subject of public discussion, especially given his age and prior medical history, including brain aneurysms in 1988. The articles also briefly mention Donald Trump's recent physical, which reported him to be in excellent health.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard